Anna Wärme1,2, Henrik Hadimeri3, Salmir Nasic4, Bernd Stegmayr5. 1. Dept of Internal Medicine and Clinical Nutrition, Institution of Medicine, University of Gothenburg, Gothenburg, Sweden. anna.warme@vgregion.se. 2. Department of Nephrology, Skaraborg hospital, 541 85, Skovde, Sweden. anna.warme@vgregion.se. 3. Dept of Internal Medicine and Clinical Nutrition, Institution of Medicine, University of Gothenburg, Gothenburg, Sweden. 4. Research and Development Centre, Skaraborg Hospital, Skovde, Sweden. 5. Dept of Public Health and Clinical Medicine, Umea University, Umea, Sweden.
Abstract
BACKGROUND: Patients in maintenance hemodialysis (HD) need a patent vascular access for optimal treatment. The recommended first choice is a native arteriovenous fistula (AVF). Complications of AVF are frequent and include thrombosis, stenosis and infections leading to worsening of dialysis efficacy. Some known risk factors are age, gender and the presence of diabetes mellitus. The aim was to investigate if further risk variables are associated with dysfunctional AVF. METHODS: This retrospective observational study included 153 chronic HD patients (Cases) referred to a total of 473 radiological investigations due to clinically suspected complications of their native AVF. Another group of chronic HD patients (n = 52) who had a native AVF but were without history of previous complications for at least 2 years were controls. Statistical analyses included ANOVA, logistic regression, parametric and non-parametric methods such as Student's T-test and Mann-Whitney test. RESULTS: Among Cases, at least one significant stenosis (> 50% of the lumen) was detected in 348 occasions. Subsequent PTA was performed in 248 (71%). Median erythropoiesis-stimulating agent (ESA) weekly doses were higher in Cases than in Controls (8000 vs 5000 IU, p < 0.001). Cases received higher doses of intravenous iron/week than the Controls before the investigation (median 50 mg vs 25 mg, p = 0.004) and low molecular weight heparin (LMWH, p = 0.028). Compared to Controls, Cases had a lower level of parathyroid hormone (median 25 vs 20 ρmol/L, p = 0.009). In patients with diabetes mellitus, HbA1c was higher among Cases than Controls (50 vs 38 mmol/mol, p < 0.001). Multiple regression analysis revealed significant associations between Cases and female gender, prescription of doxazocin, and doses of ESA and LMWH. There was no difference between the groups regarding hemoglobin, CRP or ferritin. CONCLUSION: In conclusion, the present study indicated that the factors associated with AVF problems were high doses of ESA, iron administration, and tendency of thromboembolism (indicated by high LMWH doses); the use of doxazocin prescription, however, requires further investigation.
BACKGROUND: Patients in maintenance hemodialysis (HD) need a patent vascular access for optimal treatment. The recommended first choice is a native arteriovenous fistula (AVF). Complications of AVF are frequent and include thrombosis, stenosis and infections leading to worsening of dialysis efficacy. Some known risk factors are age, gender and the presence of diabetes mellitus. The aim was to investigate if further risk variables are associated with dysfunctional AVF. METHODS: This retrospective observational study included 153 chronic HD patients (Cases) referred to a total of 473 radiological investigations due to clinically suspected complications of their native AVF. Another group of chronic HD patients (n = 52) who had a native AVF but were without history of previous complications for at least 2 years were controls. Statistical analyses included ANOVA, logistic regression, parametric and non-parametric methods such as Student's T-test and Mann-Whitney test. RESULTS: Among Cases, at least one significant stenosis (> 50% of the lumen) was detected in 348 occasions. Subsequent PTA was performed in 248 (71%). Median erythropoiesis-stimulating agent (ESA) weekly doses were higher in Cases than in Controls (8000 vs 5000 IU, p < 0.001). Cases received higher doses of intravenous iron/week than the Controls before the investigation (median 50 mg vs 25 mg, p = 0.004) and low molecular weight heparin (LMWH, p = 0.028). Compared to Controls, Cases had a lower level of parathyroid hormone (median 25 vs 20 ρmol/L, p = 0.009). In patients with diabetes mellitus, HbA1c was higher among Cases than Controls (50 vs 38 mmol/mol, p < 0.001). Multiple regression analysis revealed significant associations between Cases and female gender, prescription of doxazocin, and doses of ESA and LMWH. There was no difference between the groups regarding hemoglobin, CRP or ferritin. CONCLUSION: In conclusion, the present study indicated that the factors associated with AVF problems were high doses of ESA, iron administration, and tendency of thromboembolism (indicated by high LMWH doses); the use of doxazocin prescription, however, requires further investigation.
Authors: Tammy Hod; Ranil N Desilva; Bhanu K Patibandla; Yael Vin; Robert S Brown; Alexander S Goldfarb-Rumyantzev Journal: Hemodial Int Date: 2013-10-28 Impact factor: 1.812
Authors: Jürg Schmidli; Matthias K Widmer; Carlo Basile; Gianmarco de Donato; Maurizio Gallieni; Christopher P Gibbons; Patrick Haage; George Hamilton; Ulf Hedin; Lars Kamper; Miltos K Lazarides; Ben Lindsey; Gaspar Mestres; Marisa Pegoraro; Joy Roy; Carlo Setacci; David Shemesh; Jan H M Tordoir; Magda van Loon; Philippe Kolh; Gert J de Borst; Nabil Chakfe; Sebastian Debus; Rob Hinchliffe; Stavros Kakkos; Igor Koncar; Jes Lindholt; Ross Naylor; Melina Vega de Ceniga; Frank Vermassen; Fabio Verzini; Markus Mohaupt; Jean-Baptiste Ricco; Ramon Roca-Tey Journal: Eur J Vasc Endovasc Surg Date: 2018-05-02 Impact factor: 7.069
Authors: Rafael Pérez-García; Javier Varas; Alejandro Cives; Alejandro Martín-Malo; Pedro Aljama; Rosa Ramos; Julio Pascual; Stefano Stuard; Bernard Canaud; José Ignacio Merello Journal: Nephrol Dial Transplant Date: 2018-04-01 Impact factor: 5.992
Authors: Khalid Bashar; Adeel Zafar; Sawsan Elsheikh; Donagh A Healy; Mary Clarke-Moloney; Liam Casserly; Paul E Burke; Eamon G Kavanagh; Stewart R Walsh Journal: PLoS One Date: 2015-03-13 Impact factor: 3.240